Venom immunotherapy during COVID-19 pandemic: Experience from a University Allergy Center in Northern Italy

World Allergy Organization Journal - Tập 13 - Trang 100489 - 2020
Alessandro Dell’Edera1, Franco Borghesan1, Elisabetta Favero1, Marcello Rattazzi1, Riccardo Scarpa1, Leonardo Tartaglia1, Carlo Agostini1, Francesco Cinetto1
1Allergy and Clinical Immunology Center, University of Padua, Department of Internal Medicine, Internal Medicine I Unit, Ca' Foncello Hospital, Treviso, Italy

Tài liệu tham khảo

Fauci, 2020, Covid-19 — navigating the uncharted, N Engl J Med, 382, 1268, 10.1056/NEJMe2002387

Wu, 2020, TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib, J Microbiol Immunol Infect, 10.1016/j.jmii.2020.03.005

Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA, 323, 1239, 10.1001/jama.2020.2648

Li, 2020, Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan, J Allergy Clin Immunol, 10.1016/j.jaci.2020.04.006

Glenis, 2020, Allergic respiratory disease care in the COVID-19 era: a EUFOREA statement, World Allergy Organ J, 13, 100124, 10.1016/j.waojou.2020.100124

Jutel, 2013, Mechanisms of allergen- specific immunotherapy and novel ways for vaccine development, Allergol Int, 62, 425, 10.2332/allergolint.13-RAI-0608

Pfaar, 2019, Perspectives in allergen immunotherapy: 2019 and beyond, Allergy, 74, 3, 10.1111/all.14077

Boonpiyathad, 2019, Il-10 producing T and B cells in allergy, Semin Immunol, 44, 101326, 10.1016/j.smim.2019.101326

Akdis, 2014, Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens, J Allergy Clin Immunol, 133, 621, 10.1016/j.jaci.2013.12.1088

Thông tin
Thông tin xuất bản

World Allergy Organization Journal

Tập 13

100489

Thông tin tác giả